» Articles » PMID: 18570968

Genetic and Phenotypic Characterization of Sylvatic Dengue Virus Type 2 Strains

Overview
Journal Virology
Specialty Microbiology
Date 2008 Jun 24
PMID 18570968
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The four serotypes of endemic dengue viruses (DENV) circulate between humans and peridomestic Aedes mosquitoes. At present endemic DENV infect 100 million people per year, and a third of the global population is at risk. In contrast, sylvatic DENV strains are maintained in a transmission cycle between nonhuman primates and sylvatic Aedes species, and are evolutionarily and ecologically distinct from endemic DENV strains. Phylogenetic analyses place sylvatic strains basal to each of the endemic serotypes, supporting the hypothesis that each of the endemic DENV serotypes emerged independently from sylvatic ancestors. We utilized complete genome analyses of both sylvatic and endemic DENV serotype 2 (DENV-2) to expand our understanding of their genetic relationships. A high degree of conservation was observed in both the 5'- and 3'-untranslated genome regions, whereas considerable differences at the nucleotide and amino acid levels were observed within the open reading frame. Additionally, replication of the two genotypes was compared in cultured cells, where endemic DENV strains produced a significantly higher output of progeny in human liver cells, but not in monkey kidney or mosquito cells. Understanding the genetic relationships and phenotypic differences between endemic and sylvatic DENV genotypes may provide valuable insight into DENV emergence and guide monitoring of future outbreaks.

Citing Articles

Mechanisms of Yellow Fever Transmission: Gleaning the Overlooked Records of Importance and Identifying Problems, Puzzles, Serious Issues, Surprises and Research Questions.

Kuno G Viruses. 2024; 16(1).

PMID: 38257784 PMC: 10820296. DOI: 10.3390/v16010084.


Changing Ecotypes of Dengue Virus 2 Serotype in Nigeria and the Emergence of Cosmopolitan and Asian I Lineages, 1966-2019.

Onoja B, Maiga M, Adesola R, Adamu A, Adegboye O Vaccines (Basel). 2023; 11(3.

PMID: 36992135 PMC: 10052944. DOI: 10.3390/vaccines11030547.


Construction and Rescue of a DNA-Launched DENV2 Infectious Clone.

Holliday M, Corliss L, Lennemann N Viruses. 2023; 15(2).

PMID: 36851490 PMC: 9959642. DOI: 10.3390/v15020275.


Genetic Adaptation by Dengue Virus Serotype 2 to Enhance Infection of Mosquito Midguts.

Erb S, Butrapet S, Roehrig J, Huang C, Blair C Viruses. 2022; 14(7).

PMID: 35891549 PMC: 9325310. DOI: 10.3390/v14071569.


Traditional Knowledge to Contemporary Medication in the Treatment of Infectious Disease Dengue: A Review.

Dhiman M, Sharma L, Dadhich A, Dhawan P, Sharma M Front Pharmacol. 2022; 13:750494.

PMID: 35359838 PMC: 8963989. DOI: 10.3389/fphar.2022.750494.


References
1.
Blackwell J, Brinton M . BHK cell proteins that bind to the 3' stem-loop structure of the West Nile virus genome RNA. J Virol. 1995; 69(9):5650-8. PMC: 189422. DOI: 10.1128/JVI.69.9.5650-5658.1995. View

2.
Munoz-Jordan J, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, Lipkin W . Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol. 2005; 79(13):8004-13. PMC: 1143737. DOI: 10.1128/JVI.79.13.8004-8013.2005. View

3.
Modis Y, Ogata S, Clements D, Harrison S . Structure of the dengue virus envelope protein after membrane fusion. Nature. 2004; 427(6972):313-9. DOI: 10.1038/nature02165. View

4.
Marchette N, Halstead S, Falkler Jr W, Stenhouse A, Nash D . Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J Infect Dis. 1973; 128(1):23-30. DOI: 10.1093/infdis/128.1.23. View

5.
Kummerer B, Rice C . Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J Virol. 2002; 76(10):4773-84. PMC: 136122. DOI: 10.1128/jvi.76.10.4773-4784.2002. View